Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.970
+0.260 (9.59%)
At close: Jun 26, 2026, 4:00 PM EDT
2.912
-0.058 (-1.97%)
Pre-market: Jun 29, 2026, 7:50 AM EDT
Psyence Biomedical Employees
Psyence Biomedical had 12 employees as of March 31, 2026. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$578,035
Market Cap
11.33M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 12 | 0 | - |
| Mar 31, 2025 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| OSR Health | 22 |
| CalciMedica | 16 |
| Theriva Biologics | 16 |
| BioRestorative Therapies | 14 |
| Kiora Pharmaceuticals | 13 |
| Aprea Therapeutics | 8 |
| Intensity Therapeutics | 7 |
| Akari Therapeutics, | 6 |
PBM News
- 12 days ago - Tredium Solutions Selected to Support Scripius' Pharmacy Benefits Platform - Business Wire
- 6 weeks ago - Psyence Biomedical announces U.S. engagement initiative focused on ibogaine - TheFly
- 6 weeks ago - Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing - GlobeNewsWire
- 2 months ago - Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder - GlobeNewsWire
- 2 months ago - Psyence Biomedical provides update on position in global ibogaine market - TheFly
- 2 months ago - Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source - GlobeNewsWire
- 2 months ago - Why Is Psyence Biomedical Stock (PBM) Up Today? - TipRanks
- 2 months ago - Psyence Biomedical Ltd trading resumes - TheFly